ECMO Braile Biomédica® in COVID-19 Patients (ECMO_COVID)

Braile Biomedica

Status: Enrolling

Conditions: COVID-19

Treatments: Device: Patients underwent cardiorespiratory support

Study type: Observational

Funder types: Industry

Identifiers

NCT06086405

ECMO COVID

Details and patient eligibility

About

Retrospective data collection to evaluate the gas transfer capacity of the Braile Biomédica® OxyPrime® ECMO BRCoating® Membrane Oxygenator in COVID-19 patients during the pandemic.

Full description

Multicenter, retrospective, non-comparative, non-randomized study to assess the clinical performance of the OxyPrime® ECMO BRCoating® Membrane Oxygenator in adult patients with COVID-19

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients ≥ 18 years old, with a previous diagnosis of COVID-19, who were placed on ECMO using the Oxyprime® ECMO Braile Biomédica® Membrane Oxygenator, from March 2020 to July 2022, following the Instructions for Use (IFU) of the products.

Exclusion criteria

• Patients without a diagnosis of COVID-19